Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Growth 2022-2028
As the global economy mends, the 2021 growth of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs will have significant change from previous year. According to our latest study, the global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market size is USD million in 2022 from USD 2311.6 million in 2021, with a change of % between 2021 and 2022. The global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market size will reach USD 2056 million in 2028, growing at a CAGR of -1.7% over the analysis period.
The United States Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market, reaching US$ million by the year 2028. As for the Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs players cover Heron Therapeutics, Merck, Eisai, and Mundipharma, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
5-HT3 Inhibitors
NK1 Inhibitors
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Acute CINV
Delayed CINV
Breakthrough CINV
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Heron Therapeutics
Merck
Eisai
Mundipharma
Qilu Pharma
Teva
Novartis
Roche
Mylan
Baxter
GSK
Helsinn
Southwest Pharma
Haisco
Sun Pharma
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs by Country/Region, 2017, 2022 & 2028
2.2 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Segment by Type
2.2.1 5-HT3 Inhibitors
2.2.2 NK1 Inhibitors
2.2.3 Others
2.3 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type
2.3.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Type (2017-2022)
2.3.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue and Market Share by Type (2017-2022)
2.3.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sale Price by Type (2017-2022)
2.4 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Segment by Application
2.4.1 Acute CINV
2.4.2 Delayed CINV
2.4.3 Breakthrough CINV
2.4.4 Others
2.5 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application
2.5.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sale Market Share by Application (2017-2022)
2.5.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue and Market Share by Application (2017-2022)
2.5.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sale Price by Application (2017-2022)
3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs by Company
3.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Breakdown Data by Company
3.1.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Annual Sales by Company (2020-2022)
3.1.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Company (2020-2022)
3.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Annual Revenue by Company (2020-2022)
3.2.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Company (2020-2022)
3.2.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Company (2020-2022)
3.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sale Price by Company
3.4 Key Manufacturers Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Location Distribution
3.4.2 Players Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs by Geographic Region
4.1 World Historic Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Geographic Region (2017-2022)
4.1.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Annual Revenue by Geographic Region
4.2 World Historic Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Country/Region (2017-2022)
4.2.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Annual Sales by Country/Region (2017-2022)
4.2.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Annual Revenue by Country/Region
4.3 Americas Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Growth
4.4 APAC Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Growth
4.5 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Growth
4.6 Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Growth
5 Americas
5.1 Americas Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country
5.1.1 Americas Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2017-2022)
5.1.2 Americas Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country (2017-2022)
5.2 Americas Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type
5.3 Americas Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Region
6.1.1 APAC Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Region (2017-2022)
6.1.2 APAC Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Region (2017-2022)
6.2 APAC Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type
6.3 APAC Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs by Country
7.1.1 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2017-2022)
7.1.2 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country (2017-2022)
7.2 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type
7.3 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs by Country
8.1.1 Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2017-2022)
8.1.2 Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country (2017-2022)
8.2 Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type
8.3 Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs
10.3 Manufacturing Process Analysis of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs
10.4 Industry Chain Structure of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Distributors
11.3 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Customer
12 World Forecast Review for Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs by Geographic Region
12.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Forecast by Region
12.1.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Forecast by Region (2023-2028)
12.1.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Forecast by Type
12.7 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Forecast by Application
13 Key Players Analysis
13.1 Heron Therapeutics
13.1.1 Heron Therapeutics Company Information
13.1.2 Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Offered
13.1.3 Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Heron Therapeutics Main Business Overview
13.1.5 Heron Therapeutics Latest Developments
13.2 Merck
13.2.1 Merck Company Information
13.2.2 Merck Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Offered
13.2.3 Merck Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Merck Main Business Overview
13.2.5 Merck Latest Developments
13.3 Eisai
13.3.1 Eisai Company Information
13.3.2 Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Offered
13.3.3 Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Eisai Main Business Overview
13.3.5 Eisai Latest Developments
13.4 Mundipharma
13.4.1 Mundipharma Company Information
13.4.2 Mundipharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Offered
13.4.3 Mundipharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Mundipharma Main Business Overview
13.4.5 Mundipharma Latest Developments
13.5 Qilu Pharma
13.5.1 Qilu Pharma Company Information
13.5.2 Qilu Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Offered
13.5.3 Qilu Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Qilu Pharma Main Business Overview
13.5.5 Qilu Pharma Latest Developments
13.6 Teva
13.6.1 Teva Company Information
13.6.2 Teva Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Offered
13.6.3 Teva Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Teva Main Business Overview
13.6.5 Teva Latest Developments
13.7 Novartis
13.7.1 Novartis Company Information
13.7.2 Novartis Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Offered
13.7.3 Novartis Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Novartis Main Business Overview
13.7.5 Novartis Latest Developments
13.8 Roche
13.8.1 Roche Company Information
13.8.2 Roche Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Offered
13.8.3 Roche Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Roche Main Business Overview
13.8.5 Roche Latest Developments
13.9 Mylan
13.9.1 Mylan Company Information
13.9.2 Mylan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Offered
13.9.3 Mylan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Mylan Main Business Overview
13.9.5 Mylan Latest Developments
13.10 Baxter
13.10.1 Baxter Company Information
13.10.2 Baxter Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Offered
13.10.3 Baxter Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Baxter Main Business Overview
13.10.5 Baxter Latest Developments
13.11 GSK
13.11.1 GSK Company Information
13.11.2 GSK Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Offered
13.11.3 GSK Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 GSK Main Business Overview
13.11.5 GSK Latest Developments
13.12 Helsinn
13.12.1 Helsinn Company Information
13.12.2 Helsinn Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Offered
13.12.3 Helsinn Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Helsinn Main Business Overview
13.12.5 Helsinn Latest Developments
13.13 Southwest Pharma
13.13.1 Southwest Pharma Company Information
13.13.2 Southwest Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Offered
13.13.3 Southwest Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Southwest Pharma Main Business Overview
13.13.5 Southwest Pharma Latest Developments
13.14 Haisco
13.14.1 Haisco Company Information
13.14.2 Haisco Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Offered
13.14.3 Haisco Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Haisco Main Business Overview
13.14.5 Haisco Latest Developments
13.15 Sun Pharma
13.15.1 Sun Pharma Company Information
13.15.2 Sun Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Offered
13.15.3 Sun Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Sun Pharma Main Business Overview
13.15.5 Sun Pharma Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 5-HT3 Inhibitors
Table 4. Major Players of NK1 Inhibitors
Table 5. Major Players of Others
Table 6. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type (2017-2022) & (M Units)
Table 7. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Type (2017-2022)
Table 8. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Type (2017-2022) & ($ million)
Table 9. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Type (2017-2022)
Table 10. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sale Price by Type (2017-2022) & (US$/Unit)
Table 11. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application (2017-2022) & (M Units)
Table 12. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Application (2017-2022)
Table 13. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Application (2017-2022)
Table 14. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Application (2017-2022)
Table 15. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sale Price by Application (2017-2022) & (US$/Unit)
Table 16. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Company (2020-2022) & (M Units)
Table 17. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Company (2020-2022)
Table 18. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Company (2020-2022)
Table 20. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sale Price by Company (2020-2022) & (US$/Unit)
Table 21. Key Manufacturers Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Producing Area Distribution and Sales Area
Table 22. Players Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Products Offered
Table 23. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Geographic Region (2017-2022) & (M Units)
Table 27. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share Geographic Region (2017-2022)
Table 28. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country/Region (2017-2022) & (M Units)
Table 31. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Country/Region (2017-2022)
Table 32. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2017-2022) & (M Units)
Table 35. Americas Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Country (2017-2022)
Table 36. Americas Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Country (2017-2022)
Table 38. Americas Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type (2017-2022) & (M Units)
Table 39. Americas Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Type (2017-2022)
Table 40. Americas Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application (2017-2022) & (M Units)
Table 41. Americas Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Application (2017-2022)
Table 42. APAC Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Region (2017-2022) & (M Units)
Table 43. APAC Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Region (2017-2022)
Table 44. APAC Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Region (2017-2022)
Table 46. APAC Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type (2017-2022) & (M Units)
Table 47. APAC Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Type (2017-2022)
Table 48. APAC Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application (2017-2022) & (M Units)
Table 49. APAC Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Application (2017-2022)
Table 50. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2017-2022) & (M Units)
Table 51. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Country (2017-2022)
Table 52. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Country (2017-2022)
Table 54. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type (2017-2022) & (M Units)
Table 55. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Type (2017-2022)
Table 56. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application (2017-2022) & (M Units)
Table 57. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2017-2022) & (M Units)
Table 59. Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type (2017-2022) & (M Units)
Table 63. Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application (2017-2022) & (M Units)
Table 65. Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs
Table 67. Key Market Challenges & Risks of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs
Table 68. Key Industry Trends of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs
Table 69. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Distributors List
Table 72. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Customer List
Table 73. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Forecast by Region (2023-2028) & (M Units)
Table 74. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Forecast by Region
Table 75. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Forecast by Country (2023-2028) & (M Units)
Table 78. Americas Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Forecast by Region (2023-2028) & (M Units)
Table 80. APAC Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Forecast by Country (2023-2028) & (M Units)
Table 82. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Forecast by Country (2023-2028) & (M Units)
Table 84. Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Forecast by Type (2023-2028) & (M Units)
Table 86. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Forecast by Application (2023-2028) & (M Units)
Table 90. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share Forecast by Application (2023-2028)
Table 93. Heron Therapeutics Basic Information, Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 94. Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Offered
Table 95. Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 96. Heron Therapeutics Main Business
Table 97. Heron Therapeutics Latest Developments
Table 98. Merck Basic Information, Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 99. Merck Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Offered
Table 100. Merck Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 101. Merck Main Business
Table 102. Merck Latest Developments
Table 103. Eisai Basic Information, Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 104. Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Offered
Table 105. Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 106. Eisai Main Business
Table 107. Eisai Latest Developments
Table 108. Mundipharma Basic Information, Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 109. Mundipharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Offered
Table 110. Mundipharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 111. Mundipharma Main Business
Table 112. Mundipharma Latest Developments
Table 113. Qilu Pharma Basic Information, Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 114. Qilu Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Offered
Table 115. Qilu Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 116. Qilu Pharma Main Business
Table 117. Qilu Pharma Latest Developments
Table 118. Teva Basic Information, Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 119. Teva Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Offered
Table 120. Teva Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 121. Teva Main Business
Table 122. Teva Latest Developments
Table 123. Novartis Basic Information, Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 124. Novartis Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Offered
Table 125. Novartis Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 126. Novartis Main Business
Table 127. Novartis Latest Developments
Table 128. Roche Basic Information, Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 129. Roche Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Offered
Table 130. Roche Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 131. Roche Main Business
Table 132. Roche Latest Developments
Table 133. Mylan Basic Information, Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 134. Mylan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Offered
Table 135. Mylan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 136. Mylan Main Business
Table 137. Mylan Latest Developments
Table 138. Baxter Basic Information, Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 139. Baxter Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Offered
Table 140. Baxter Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 141. Baxter Main Business
Table 142. Baxter Latest Developments
Table 143. GSK Basic Information, Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 144. GSK Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Offered
Table 145. GSK Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 146. GSK Main Business
Table 147. GSK Latest Developments
Table 148. Helsinn Basic Information, Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 149. Helsinn Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Offered
Table 150. Helsinn Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 151. Helsinn Main Business
Table 152. Helsinn Latest Developments
Table 153. Southwest Pharma Basic Information, Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 154. Southwest Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Offered
Table 155. Southwest Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 156. Southwest Pharma Main Business
Table 157. Southwest Pharma Latest Developments
Table 158. Haisco Basic Information, Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 159. Haisco Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Offered
Table 160. Haisco Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 161. Haisco Main Business
Table 162. Haisco Latest Developments
Table 163. Sun Pharma Basic Information, Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 164. Sun Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Offered
Table 165. Sun Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 166. Sun Pharma Main Business
Table 167. Sun Pharma Latest Developments
List of Figures
Figure 1. Picture of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs
Figure 2. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Growth Rate 2017-2028 (M Units)
Figure 7. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 5-HT3 Inhibitors
Figure 10. Product Picture of NK1 Inhibitors
Figure 11. Product Picture of Others
Figure 12. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Type in 2021
Figure 13. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Type (2017-2022)
Figure 14. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumed in Acute CINV
Figure 15. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market: Acute CINV (2017-2022) & (M Units)
Figure 16. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumed in Delayed CINV
Figure 17. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market: Delayed CINV (2017-2022) & (M Units)
Figure 18. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumed in Breakthrough CINV
Figure 19. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market: Breakthrough CINV (2017-2022) & (M Units)
Figure 20. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumed in Others
Figure 21. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market: Others (2017-2022) & (M Units)
Figure 22. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Application (2017-2022)
Figure 23. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Application in 2021
Figure 24. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market by Company in 2021 ($ Million)
Figure 25. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Company in 2021
Figure 26. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Geographic Region (2017-2022)
Figure 27. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Geographic Region in 2021
Figure 28. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Region (2017-2022)
Figure 29. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Country/Region in 2021
Figure 30. Americas Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales 2017-2022 (M Units)
Figure 31. Americas Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue 2017-2022 ($ Millions)
Figure 32. APAC Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales 2017-2022 (M Units)
Figure 33. APAC Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue 2017-2022 ($ Millions)
Figure 34. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales 2017-2022 (M Units)
Figure 35. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue 2017-2022 ($ Millions)
Figure 36. Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales 2017-2022 (M Units)
Figure 37. Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue 2017-2022 ($ Millions)
Figure 38. Americas Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Country in 2021
Figure 39. Americas Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Country in 2021
Figure 40. United States Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 41. Canada Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 42. Mexico Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 43. Brazil Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 44. APAC Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Region in 2021
Figure 45. APAC Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Regions in 2021
Figure 46. China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 47. Japan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 48. South Korea Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 49. Southeast Asia Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 50. India Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 51. Australia Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 52. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Country in 2021
Figure 53. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Country in 2021
Figure 54. Germany Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 55. France Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 56. UK Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 57. Italy Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 58. Russia Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 59. Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Country in 2021
Figure 60. Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Country in 2021
Figure 61. Egypt Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 62. South Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 63. Israel Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 64. Turkey Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 65. GCC Country Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 66. Manufacturing Cost Structure Analysis of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs in 2021
Figure 67. Manufacturing Process Analysis of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs
Figure 68. Industry Chain Structure of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles
